Komatsu Ltd Spons Ad (KMTUY) 17.4550 $KMTUY Cummins and

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Komatsu Ltd Spons Ad (KMTUY) 17.4550 $KMTUY

Cummins and Komatsu Partner to Improve Global Communities through Corporate Responsibility Partnership
BusinessWire - Mon Apr 11, 9:45AM CDT
Tom Linebarger, CEO of Cummins Inc. (NYSE: CMI), and Tetsuji Ohashi, CEO of Komatsu Ltd. today announced a global corporate responsibility partnership to improve communities around the world. This partnership will build on the companies' already strong business relationship.
CMI: 113.64 (-1.49)

New Factors Move a Trending Market - Analyst Comments on Cardinal Resources, Solos Endoscopy, Kaminak Gold and Komatsu
ACCESSWIRE - Mon Mar 14, 7:06AM CDT
NEW YORK, NY / ACCESSWIRE / March 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Cardinal Resources Inc. (OTC: CDNL), Solos Endoscopy Inc. (OTC: SNDY), Kaminak Gold Corp. (OTC: KMKGF) and Komatsu Ltd. (OTC: KMTUY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

II-VI Incorporated Up to Strong Buy on Q2 Results & Buyouts
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 1:55PM CST
Zacks Investment Research upgraded II-VI Incorporated (IIVI) to a Zacks Rank #1 (Strong Buy) on Feb 10, 2016.
GGG: 81.06 (-0.75), IIVI: 20.32 (-0.01), KAMN: 42.93 (+0.01)

Colfax Beats Q4 Earnings & Revenues, Maintains '16 Outlook
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 11:50AM CST
Colfax Corporation's (CFX) fourth-quarter 2015 adjusted earnings of 51 cents per share surpassed the Zacks Consensus Estimate of 43 cents. Also, revenues of $1,061.5 million marginally beat the Zacks Consensus Estimate of $1,016 million.
CFX: 28.18 (+0.08), MTW: 5.71 (-0.04), ASTE: 53.86 (-0.23)

Rexnord Beats Q3 Earnings, Lags Revenues; Cuts FY16 View
Zacks Equity Research - Zacks Investment Research - Thu Feb 04, 11:30AM CST
Rexnord Corporation's (RXN) adjusted earnings of 38 cents per share for third-quarter fiscal 2016 (ended Dec 31, 2015) surpassed the Zacks Consensus Estimate of 37 cents, while coming at par with the year-ago tally.
RXN: 20.69 (-0.04), MTW: 5.71 (-0.04), ASTE: 53.86 (-0.23)

Kennametal Beats Q2 Earnings & Revenues, Cuts '16 Outlook
Zacks Equity Research - Zacks Investment Research - Thu Feb 04, 11:00AM CST
Kennametal Inc. (KMT) reported adjusted earnings of 14 cents per share for second-quarter fiscal 2016 (ended Dec 31, 2015), surpassing the Zacks Consensus Estimate of 11 cents; while revenues of $524 million beat the estimate of $479 million.
KMT: 24.93 (+0.12), MTW: 5.71 (-0.04), ASTE: 53.86 (-0.23)

What Makes Joy Global (JOY) a Strong Sell?
Zacks Equity Research - Zacks Investment Research - Mon Feb 01, 7:56AM CST
Joy Global is a stock to drop as it has witnessed negative trend in earnings estimate revisions and has seen its price decline significantly.
JOY: 20.70 (+0.34)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

2026 Cannabis Reform: A Turning Point for Stock Valuations

Updated Category News Views 214

2026 Cannabis Reform: A Turning Point for Stock Valuations As we approach the end of 2025, the cannabis sector showcases a perplexing scenario for investors. Political events are creating uncertainty yet also opportunities within this evolving market. Recently, a significant Executive Order was issued, calling for a swift review of cannabis scheduling. A change like this...

Continue Reading
21Shares Unveils Innovative 2x Long Dogecoin ETF TXXD

Updated Category News Views 195

Introduction to the 21Shares 2x Long Dogecoin ETF 21Shares has recently made headlines by launching the 21Shares 2x Long Dogecoin ETF (Ticker: TXXD). This innovative exchange-traded fund enables investors to gain leveraged exposure to Dogecoin, a cryptocurrency that has gained immense popularity and support from its enthusiastic community. Designed to trade on NASDAQ,...

Continue Reading
Bicara Therapeutics Completes Impressive $362 Million IPO Success

Updated Category News Views 149

Bicara Therapeutics' Initial Public Offering: An Overview Bicara Therapeutics Inc. has achieved a remarkable milestone by completing its initial public offering (IPO) and raising about $362 million. This offering included 20,125,000 shares of common stock, each priced at $18.00. Significantly, the IPO's success also reflects the full exercise of the underwriters' option,...

Continue Reading
Marshall Group Continues Strong Growth in Third Quarter 2024

Updated Category News Views 439

Marshall Group Reports Impressive Growth in Q3 2024 In the latest financial update, Marshall Group has demonstrated remarkable performance, continuing its trajectory of profitable growth. With a 15 percent increase in net sales, reaching SEK 1,118.4 million, the company highlights its commitment to excellence and innovation. This growth is accompanied by an adjusted...

Continue Reading
Innovative Psilocybin Training Program Launches in Colorado

Updated Category News Views 169

InnerTrek Launches New Psychedelic Facilitator Training Program InnerTrek has just opened applications for an exciting training program designed for future psychedelic practitioners. This initiative marks a significant development in the realm of psychedelic healthcare. Available virtually, it welcomes students from all corners of the globe to join in and learn....

Continue Reading